Explore evidence

20.5 %Among 161 antiretroviral-naïve HIV-HBV coinfected patients in Côte d'Ivoire, 33 (20.5%) were HBeAg positive.

Côte d'Ivoirehépatite B · VIH/sidapublished 2016Journal of gastroenterology and hepatologyeurope_pmcdocument of 11 observationsDOI 10.1111/jgh.13156

7.9 per_100_person_yearsIn patients with pre-ART CD4 cell count ≥350 cells/μL, incidence of severe morbidity was 7.9 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

27 %At month 24 after ART initiation, 27% of patients in active follow-up had detectable viral loads.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

27.7 %Among HIV-2 patients, the prevalence of advanced HIV disease was 27.7% among those remaining in care.

Côte d'IvoireVIH avancé · VIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

20 %The percentage of patients with more than 200 CD4/ml increased from 20% at baseline to 36% at 6 months and 39% at 12 months.

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

10.8 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of preterm delivery was 10.8%.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

6.2 per_100_person-yearsThe incidence of loss to follow-up among HIV-infected adults receiving antiretroviral treatment was 6.2 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

90 %The most prevalent nucleoside reverse transcriptase inhibitor resistance mutations were M184I/V (90%), Q151M (24%), and S215F/Y (24%).

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

3.3 per_100_person_yearsThe incidence rate of bacterial infections was 3.3 per 100 person-years among HIV mono-infected patients.

Côte d'IvoireVIH/sidapublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 7 observationsDOI 10.4269/ajtmh.16-1016

69.2 %69.2% of enrolled HIV-infected adult patients were on antiretroviral therapy at time of sampling in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'IvoireVIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

26 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was non-AIDS-defining infections in 26% of cases.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

2.3 per_100_person-yearsHIV incidence among female sex workers in Côte d'Ivoire was estimated to be 2.3 per 100 person-years.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988

21.1 %Among the 95 HIV-2 patients enrolled in the 'success cohort', 20 (21.1%) were lost to follow-up.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

3.9 %HCV prevalence was 3.9% among HIV-infected adult patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

50 %Tuberculous meningitis has a mortality rate of up to 50% in individuals co-infected with HIV-1.

Côte d'IvoireVIH/sidapublished 2022Infectious diseases and therapyeurope_pmcdocument of 5 observations

28.8 monthsThe median follow-up duration among HIV-2-infected individuals initiating antiretroviral therapy was 28.8 months.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

77 %HIV RNA less than 50 copies/ml at 24 weeks was observed in 24 of 31 (77%) patients in the ZDV arm.

Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations

67.6 %Of 216 reported clinical indicators among 273 patients, 146 (67.6%) were reported without HIV test proposal and thus constituted missed opportunities.

Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations

13 patientsDuring 34 months of follow-up, 13 patients (21%) received second-line treatment.

Côte d'IvoireVIH/sidaobserved 34 monthspublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

67.8 %67.8% of patients had AIDS.

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

5.5 log_copies/mLThe median HIV RNA level was 5.5 log copies/mL.

Côte d'IvoireVIH/sidapublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations

67.5 %54 patients (67.5%) were naive of antiretroviral treatment, with a mean CD4 count of 45/mm³.

Côte d'IvoireVIH/sidaobserved 2005-2008published 2012Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

472 per_mm3Median CD4+ cell count was 472/mm³ among enrolled HIV-infected adult patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'IvoireVIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

12 monthsPre-ART sVCAM-1 levels significantly decreased after 12 months of ART.

Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations

70 %Detectable HCV RNA was identified in 70.0% of anti-HCV positive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations